{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:16:44Z","timestamp":1773850604251,"version":"3.50.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"9303","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1016\/s0140-6736(02)07499-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T09:32:57Z","timestamp":1027589577000},"page":"331-340","source":"Crossref","is-referenced-by-count":225,"title":["Ulcerative colitis"],"prefix":"10.1016","volume":"359","author":[{"given":"Richard J","family":"Farrell","sequence":"first","affiliation":[]},{"given":"Mark A","family":"Peppercorn","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(02)07499-8_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.med.52.1.299","article-title":"Evolving treatment strategies for inflammatory bowel disease","volume":"52","author":"Hanauer","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib3","series-title":"Inflammatory Bowel Disease","first-page":"153","article-title":"Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation","author":"Sartor","year":"2000"},{"key":"10.1016\/S0140-6736(02)07499-8_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/003655200451207","article-title":"Concordance of inflammatory bowel disease among Danish twins: results of a nationwide study","volume":"35","author":"Orholm","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/gut.29.7.990","article-title":"Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking","volume":"29","author":"Tysk","year":"1988","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/pmj.76.895.273","article-title":"Role of smoking in inflammatory bowel disease: implications for therapy","volume":"76","author":"Thomas","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/S0140-6736(02)07499-8_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/gut.29.3.352","article-title":"Smoking and inflammatory bowel disease: a case control study","volume":"29","author":"Lindberg","year":"1988","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.82.5.526","article-title":"Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry","volume":"82","author":"Miller","year":"1982","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(02)07499-8_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/gut.32.9.1016","article-title":"Smoking, humoral immunity, and ulcerative colitis","volume":"32","author":"Srivastava","year":"1991","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.293.6545.481","article-title":"Smoking and colonic mucus in ulcerative colitis","volume":"293","author":"Cope","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(02)07499-8_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2036.2001.00959.x","article-title":"Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects","volume":"15","author":"Coulie","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00054725-199905000-00001","article-title":"The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease","volume":"5","author":"Sher","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00042737-199610000-00016","article-title":"In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells","volume":"8","author":"Madretsma","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2036.1999.00585.x","article-title":"Selective COX-2 inhibitors and human inflammatory bowel disease","volume":"13","author":"McCartney","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/oxfordjournals.aje.a117246","article-title":"Increased risk of inflammatory bowel disease associated with oral contraceptive use","volume":"140","author":"Boyko","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ije\/27.3.397","article-title":"Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study\u2014Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC)","volume":"27","author":"Corrao","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib18","first-page":"1920","article-title":"Patient perceptions of causes of inflammatory bowel disease","volume":"89","author":"Theis","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006842-199307000-00004","article-title":"Stress and immunity in humans: a meta-analytic review","volume":"55","author":"Herbert","year":"1993","journal-title":"Psychosom Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/13503","article-title":"The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis","volume":"5","author":"Qiu","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1572-0241.2000.02012.x","article-title":"Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission","volume":"95","author":"Levenstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0016-5085(85)80126-8","article-title":"Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine","volume":"88","author":"Madara","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1023\/A:1026471303921","article-title":"Insecure attachment in a subgroup with ulcerative colitis defined by ANCA status","volume":"45","author":"Maunder","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF02088342","article-title":"Childhood infections and the risk of inflammatory bowel disease","volume":"39","author":"Wurzelmann","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0016-5085(94)90016-7","article-title":"Appendectomy protects against ulcerative colitis","volume":"106","author":"Rutgeerts","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1572-0241.2000.01680.x","article-title":"Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies","volume":"95","author":"Koutroubakis","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM200103153441104","article-title":"Appendectomy and protection against ulcerative colitis","volume":"344","author":"Andersson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1084\/jem.184.2.707","article-title":"Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice","volume":"184","author":"Mizoguchi","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/gast.2000.9368","article-title":"A patient with improvement of ulcerative colitis after appendectomy","volume":"119","author":"Okazaki","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.297.6641.102","article-title":"Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea","volume":"297","author":"Burke","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(02)07499-8_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jcp.51.9.657","article-title":"Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues","volume":"51","author":"Walmsley","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0016-5085(84)80055-4","article-title":"Glycoprotein composition of colonic mucosa: specific alterations in ulcerative colitis","volume":"87","author":"Podolsky","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1136\/gut.30.12.1660","article-title":"Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?","volume":"30","author":"Rhodes","year":"1989","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.274.5285.262","article-title":"Impaired defence of intestinal mucosa in mice lacking intestinal trefoil factor","volume":"274","author":"Mashimo","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0140-6736(02)07499-8_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.110.5.657","article-title":"Autoantibodies in human ulcerative colitis","volume":"110","author":"Broberger","year":"1959","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0016-5085(98)70331-2","article-title":"The search for pathogenic antigens in ulcerative colitis","volume":"114","author":"Targan","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","article-title":"Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease","volume":"102","author":"Duchmann","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","article-title":"A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease","volume":"86","author":"Saxon","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)90793-K","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4065\/71.5.431","article-title":"Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study","volume":"71","author":"Sandborn","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S0140-6736(02)07499-8_bib41","first-page":"740","article-title":"Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis","volume":"90","author":"Sandborn","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib42","first-page":"1512","article-title":"Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease","volume":"91","author":"Papo","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI111963","article-title":"Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis","volume":"76","author":"Takahashi","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(02)07499-8_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(94)90066-3","article-title":"A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody","volume":"107","author":"Bhagat","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2249.1995.tb05565.x","article-title":"Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12","volume":"99","author":"Hamilton","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib46","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.150.10.4693","article-title":"Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin","volume":"150","author":"Vashishtha","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/clim.1999.4805","article-title":"Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies","volume":"94","author":"Gordon","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib48","first-page":"1250","article-title":"Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA","volume":"40","author":"Gordon","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib49","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/IAI.68.3.1542-1548.2000","article-title":"Colonic bacteria express an ulcerative colitis pANCA-related protein epitope","volume":"68","author":"Cohavy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/S0140-6736(02)07499-8_bib50","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.1996.v110.pm8964407","article-title":"Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup","volume":"110","author":"Vasiliauskas","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM199101103240203","article-title":"Familial occurrence of inflammatory bowel disease","volume":"324","author":"Orholm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/gut.34.4.517","article-title":"Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews","volume":"34","author":"Yang","year":"1993","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib53","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1111\/j.1572-0241.1999.01526.x","article-title":"Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease","volume":"94","author":"Orholm","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib54","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)90734-5","article-title":"Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease","volume":"347","author":"Satsangi","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1096-199","article-title":"Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12","volume":"14","author":"Satsangi","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/BF02064985","article-title":"HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression","volume":"40","author":"Futami","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib57","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/gast.1997.v112.pm9178675","article-title":"Genetic markers may predict disease behavior in patients with ulcerative colitis","volume":"112","author":"Roussomoustakaki","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0016-5085(00)70210-1","article-title":"High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy","volume":"118","author":"Farrell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"Orchard","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00042737-199904000-00010","article-title":"Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies","volume":"11","author":"Papo","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/hmg\/8.2.307","article-title":"Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3","volume":"8","author":"Kyo","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib62","first-page":"1273","article-title":"Epithelial deposits of immunoglobulin G1 and activated complement co-localize with the \u201cM(r) 40kD\u201d putative auto-antigen in ulcerative colitis","volume":"6","author":"Halstensen","year":"1995","journal-title":"Adv Exp Med Biol"},{"issue":"suppl","key":"10.1016\/S0140-6736(02)07499-8_bib63","first-page":"S5","article-title":"Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases","volume":"92","author":"Sartor","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib64","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","article-title":"Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice","volume":"186","author":"Mizoguchi","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib65","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.44.6.812","article-title":"T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans","volume":"44","author":"Duchmann","year":"1999","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib66","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1172\/JCI119082","article-title":"Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis","volume":"98","author":"Boirivant","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(02)07499-8_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/gut.43.1.48","article-title":"High Fas ligand expression on lymphocytes in lesions of ulcerative colitis","volume":"43","author":"Ueyama","year":"1998","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib68","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib69","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1572-0241.1999.01372.x","article-title":"Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity","volume":"94","author":"Inoue","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(99)70128-9","article-title":"The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice","volume":"116","author":"Mizoguchi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib71","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.4049\/jimmunol.164.11.6005","article-title":"Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40\u2013CD154 interactions","volume":"164","author":"Liu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(02)07499-8_bib73","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1084\/jem.183.6.2605","article-title":"Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance","volume":"183","author":"Neurath","year":"1996","journal-title":"J Exp Med"},{"issue":"suppl","key":"10.1016\/S0140-6736(02)07499-8_bib74","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0016-5085(00)70007-2","article-title":"Therapy of inflammatory bowel disease","volume":"118","author":"Sands","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib75","first-page":"423","article-title":"A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6\u2013mercaptopurine, cyclosporine, and methotrexate","volume":"91","author":"Sandborn","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib76","series-title":"The Cochrane Library","article-title":"Oral 5\u2013aminosalicylic acid for inducing remission in ulcerative colitis (Cochrane Review)","author":"Sutherland","year":"2000"},{"key":"10.1016\/S0140-6736(02)07499-8_bib77","series-title":"The Cochrane Library","article-title":"Oral 5\u2013aminosalicylic acid for maintaining remission in ulcerative colitis (Cochrane Review)","author":"Sutherland","year":"2000"},{"key":"10.1016\/S0140-6736(02)07499-8_bib78","first-page":"1867","article-title":"A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis","volume":"92","author":"Safdi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib79","first-page":"1143","article-title":"Combined therapy with 5\u2013aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study","volume":"92","author":"d'Albasio","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0016-5085(98)70131-3","article-title":"Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study\u2014US Budesonide enema study group","volume":"115","author":"Hanauer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib81","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/gast.1996.v110.pm8964395","article-title":"Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis","volume":"110","author":"Lofberg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib82","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/00365528708991947","article-title":"A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis","volume":"22","author":"Danielsson","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1994.tb00340.x","article-title":"Budesonide versus prednisolone retention enemas in active distal ulcerative colitis","volume":"8","author":"Lofberg","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib84","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.1995.tb00421.x","article-title":"Comparison of budesonide and 5\u2013aminosalicylic acid enemas in active distal ulcerative colitis","volume":"9","author":"Lemann","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib86","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004836-199707000-00007","article-title":"Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis","volume":"25","author":"Ardizzone","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib87","first-page":"717","article-title":"The therapeutic efficacy of 6\u2013mercaptopurine in refractory ulcerative colitis","volume":"85","author":"Adler","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib88","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.47.4.514","article-title":"Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low","volume":"47","author":"Farrell","year":"2000","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6\u2013mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib90","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/gast.1996.v110.pm8613046","article-title":"Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial","volume":"110","author":"Oren","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib91","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","article-title":"Mycophenolate mofetil","volume":"34","author":"Lipsky","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib92","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1572-0241.2000.02010.x","article-title":"Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12\u2013month pilot study","volume":"95","author":"Orth","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib93","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib94","first-page":"197","article-title":"Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis: Belgian IBD Group","volume":"60","author":"Van Gossum","year":"1997","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/S0140-6736(02)07499-8_bib95","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/BF02100145","article-title":"Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses","volume":"41","author":"Carbonnel","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib96","first-page":"A1019","article-title":"Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease","volume":"110","author":"Sternthal","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib97","first-page":"A1096","article-title":"Complications during cyclosporine therapy for inflammatory bowel disease","volume":"112","author":"Stein","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.314.7077.363","article-title":"Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia","volume":"314","author":"Quan","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(02)07499-8_bib99","doi-asserted-by":"crossref","first-page":"A786","DOI":"10.1016\/S0016-5085(00)85286-5","article-title":"Two and four mg\/kg of intravenous cyclosporin are equally effective in severe attacks of ulcerative colitis","volume":"118","author":"D'Haens","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib100","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"D'Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib101","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2036.1998.00396.x","article-title":"Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis","volume":"12","author":"Stack","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib102","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","article-title":"Intravenous cyclosporin in ulcerative colitis: a five-year experience","volume":"94","author":"Cohen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-199902000-00001","article-title":"A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin","volume":"5","author":"Cohen","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib104","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00054725-199811000-00003","article-title":"Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial","volume":"4","author":"Actis","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/003655201750163051","article-title":"Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis","volume":"36","author":"Navazo","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib106","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0016-5085(94)90394-8","article-title":"A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis","volume":"106","author":"Sandborn","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib107","series-title":"The Cochrane Library","article-title":"Pharmacotherapy for inducing and maintaining remission in pouchitis (Cochrane Review)","author":"Sandborn","year":"2000"},{"key":"10.1016\/S0140-6736(02)07499-8_bib108","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0016-5085(98)70076-9","article-title":"Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study","volume":"115","author":"Turunen","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib109","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1023\/A:1026648812439","article-title":"Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial","volume":"44","author":"Gionchetti","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0140-6736(02)07499-8_bib110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00054725-200005000-00007","article-title":"Probiotics and inflammatory bowel disease: is there a scientific rationale?","volume":"6","author":"Shanahan","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib111","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib113","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","article-title":"Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis","volume":"13","author":"Venturi","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib114","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"key":"10.1016\/S0140-6736(02)07499-8_bib116","first-page":"432","article-title":"Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study","volume":"87","author":"Aslan","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib117","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-116-8-609","article-title":"Dietary supplementation with fish oil in ulcerative colitis","volume":"116","author":"Stenson","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1993.tb00085.x","article-title":"A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0899-9007(99)00231-2","article-title":"Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis","volume":"16","author":"Dichi","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/S0140-6736(02)07499-8_bib120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib121","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-126-5-199703010-00004","article-title":"Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial","volume":"126","author":"Sandborn","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib122","first-page":"769","article-title":"Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis","volume":"8","author":"Thomas","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib123","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199504133321503","article-title":"Transdermal nicotine as maintenance therapy for ulcerative colitis","volume":"332","author":"Thomas","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2036.1997.00220.x","article-title":"Nicotine enemas for active ulcerative colitis\u2014a pilot study","volume":"11","author":"Green","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib125","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.1996.d01-509.x","article-title":"Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial","volume":"10","author":"Steinhart","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.40.4.485","article-title":"Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial","volume":"40","author":"Breuer","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib127","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1572-0241.1999.872_a.x","article-title":"Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis","volume":"94","author":"Fernandez-Banares","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(98)09267-8","article-title":"Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease","volume":"354","author":"Day","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1365-2036.2000.00860.x","article-title":"Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease","volume":"14","author":"Papa","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.1997.00252.x","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with heparin: a report of 16 cases","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib131","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2000.18159","article-title":"Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis","volume":"119","author":"Panes","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib132","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2000.00802.x","article-title":"Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease","volume":"14","author":"Ang","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib133","doi-asserted-by":"crossref","first-page":"A786","DOI":"10.1016\/S0016-5085(00)85287-7","article-title":"Tacrolimus (FK506): a new immunosuppressant for steroid refractory inflammatory bowel disease","volume":"118","author":"Fellermann","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib134","first-page":"A2530","article-title":"Infliximab is an effective therapeutic agent for ulcerative colitis","volume":"95","author":"Chey","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00054725-200105000-00001","article-title":"Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study","volume":"7","author":"Sands","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib136","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.1997.00251.x","article-title":"Treatment of ulcerative colitis with an engineered human anti-TNF alpha antibody CDP571","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib137","first-page":"1","article-title":"The immuno-inflammatory reaction in Crohn's disease and ulcerative colitis: characterisation, genetics and clinical application: focus on TNF alpha","volume":"64","author":"Louis","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/S0140-6736(02)07499-8_bib138","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer: a population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(02)07499-8_bib139","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/gast.2001.24052","article-title":"Family history as a risk factor for colorectal cancer in inflammatory bowel disease","volume":"120","author":"Askling","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.48.3.430","article-title":"Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?","volume":"48","author":"Jayaram","year":"2001","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib141","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/gast.2001.22434","article-title":"Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis","volume":"120","author":"Heuschen","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib142","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.2000.00698.x","article-title":"Colorectal cancer prevention in ulcerative colitis: a case-control study","volume":"14","author":"Eaden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib143","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0016-5085(94)90068-X","article-title":"Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study","volume":"107","author":"Pinczowski","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib144","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1046\/j.1365-2036.1999.00652.x","article-title":"Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?","volume":"13","author":"Bus","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0140-6736(02)07499-8_bib145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","article-title":"The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis","volume":"112","author":"Lashner","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib146","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00054725-199808000-00007","article-title":"Risk factors and distinguishing features of cancer in IBD","volume":"4","author":"Ekbom","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0140-6736(02)07499-8_bib147","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(94)90813-3","article-title":"Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?","volume":"343","author":"Bernstein","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)07499-8_bib148","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004836-200102000-00003","article-title":"Surveillance issues in inflammatory bowel disease: ulcerative colitis","volume":"32","author":"Provenzale","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib149","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.47.2.251","article-title":"The Vienna classification of gastrointestinal epithelial neoplasia","volume":"47","author":"Schlemper","year":"2000","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/096914139700400305","article-title":"Evaluation of surveillance programmes for colorectal cancer in ulcerative colitis patients by case-control studies: methodological considerations","volume":"4","author":"Zack","year":"1997","journal-title":"J Med Screen"},{"key":"10.1016\/S0140-6736(02)07499-8_bib151","first-page":"204","article-title":"Ulcerative colitis practice guidelines in adults\u2014American College of Gastroenterology, Practice Parameters Committee","volume":"92","author":"Kornbluth","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S0140-6736(02)07499-8_bib152","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5107(00)70405-6","article-title":"How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance","volume":"51","author":"Eaden","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/S0140-6736(02)07499-8_bib153","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0016-5085(99)70278-7","article-title":"Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis","volume":"117","author":"Engelsgjerd","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib154","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0016-5085(99)70279-9","article-title":"Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps","volume":"117","author":"Rubin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/gut.41.4.557","article-title":"Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report","volume":"41","author":"Breslin","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib156","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/gut.38.3.376","article-title":"Seasonal variations in the onset of ulcerative colitis","volume":"38","author":"Moum","year":"1996","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(02)07499-8_bib157","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1997.v112.pm9041233","article-title":"Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591","volume":"112","author":"Roberts","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib158","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1053\/gast.1997.v112.pm9041232","article-title":"A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis\u2014The European Zileuton Study Group For Ulcerative Colitis","volume":"112","author":"Hawkey","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib159","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0016-5085(98)70011-3","article-title":"Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial","volume":"115","author":"Stack","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(02)07499-8_bib160","first-page":"A1080","article-title":"Safety and tolerance of rHuIL-10 treatment in patients with mild\/moderate active ulcerative colitis","volume":"114","author":"Schreiber","year":"1998","journal-title":"Gastroenterology"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673602074998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673602074998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T15:52:43Z","timestamp":1680709963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673602074998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":160,"journal-issue":{"issue":"9303","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0140673602074998"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(02)07499-8","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}